International Journal of Advanced Culture Technology

The International Promotion Agency of Culture Technology (국제문화기술진흥원)
권호 표지
DOI QR코드

DOI QR Code

Blood test results from simultaneous infection of other respiratory viruses in COVID-19 patients

  • Received : 2022.11.26
  • Accepted : 2022.12.09
  • Published : 2022.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Since 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly, infecting millions of people worldwide. On March 11, 2020, the World Health Organization declared coronavirus disease (COVID-19) a pandemic owing to the worldwide spread of SARS-CoV-2, which created an unprecedented burden on the global healthcare system. In this context, there are increasing concerns regarding co-infections with other respiratory viruses, such as the influenza virus. In this study, clinical data of patients infected with SARS-CoV-2 and other respiratory viruses were compared with patients infected with SARS-CoV-2 alone. The hematology and blood biochemistry results of 178 patients infected with SARS-CoV-2 , who were tested on admission, were retrospectively reviewed. In patients with SARS-CoV-2 and adenovirus co-infection, C-reactive protein levels were elevated on admission, whereas lactate dehydrogenase (LDH), prothrombin time, international normalized ratio, activated partial thromboplastin clotting time, and bilirubin values were all within the normal range. Moreover, patients with SARS-CoV-2 and human bocavirus co-infection had low LDH and high bilirubin levels on admission. These findings reveal the clinical features of respiratory virus and SARS-CoV-2 co-infections and support the development of appropriate approaches for treating patients with SARS-CoV-2 and other respiratory virus co-infections.

Keywords

Acknowledgement

Sources of funding: The present research was supported by the research fund of Dankook university in 2006.

References

  1. E.M. Castillo, C.J. Coyne, J.J. Brennan, and C.A. Tomaszewski, "Rates of coinfection with other respiratory pathogens in patients positive for coronavirus disease 2019 (COVID-19)," Journal of the American College of Emergency Physicians Open, Vol. 1, No. 4, pp. 592-596, July 2020. DOI: 10.1002/emp2.12172
  2. Y.G. Kim, H. Park, S.Y. Kim, K.H. Hong, M.J. Kim, J.S. Lee, et al., "Rates of coinfection between SARSCoV-2 and other respiratory viruses in Korea," Annals of Laboratory Medicine, Vol. 42, No. 1, pp, 110-112, Jan 2022. DOI: https://doi.org/10.3343/alm.2022.42.1.110
  3. K.H. Roh, Y.K. Kim, S.W. Kim, E.R. Kang, Y.J. Yang, S.K. Jung, et al., "Coinfections with respiratory pathogens among COVID-19 patients in Korea," Canadian Journal of Infectious Disease and Medical Microbiology, Vol. 2021, 6651045, May 2021. DOI:https://doi.org/10.1155/2021/6651045
  4. C.C. Lai, C.Y. Wang, and P.R. Hsueh, "Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents?" Journal of Microbiology, Immunology and Infection, Vol. 53, No. 4, pp. 505-512, May 2020. DOI:https://doi.org/10.1016/j.jmii.2020.05.013
  5. D.M. Quinones-Laveriano, A. Soto, L. Quilca-Barrera, "Frequency of coinfection by respiratory pathogens and its impact on the prognosis of patients with COVID-19," Revista de la Facultad de Medicina Humana, Vol. 21, No. 3, pp. 617-629, July 2021. DOI:10.25176/RFMH.v21i3.3520
  6. J.S. Park, S.Y. Chu, Y.Y. Shin, I.K. Ryu, C.L. Tang, J. Choi, et al. "Comparison of clinical severity between single- and coinfections of respiratory syncytial virus and influenza virus with common respiratory viruses," Allergy, Asthma & Respiratory Disease, Vol. 7, No. 2, pp. 86-91, Apr 2019. DOI: https://doi.org10.4168aard.019 7.2.86 https://doi.org/10.4168aard.0197.2.86
  7. D.D. Zhang, M.E. Acree, J.P. Ridgway, N. Shah, A. Hazra, U. Ravichandran U, et al., "Characterizing coinfection in children with COVID-19: A dual center retrospective analysis," Infection Control & Hospital Epidemiology, Vol. 42, No. 9, pp. 1160-1162, Sept 2021. DOI:http://doi.org/10.1017/ice.2020.1221
  8. J.H. Choi, J.Y. Paik, C.E. Hwa, and H.J. Lee, "Epidemiologic Characteristics of Human Bocavirus-Associated Respiratory Infection in Children," Korean Journal of Pediatric Infectious Diseases, Vol. 18, No. 1, pp. 61-67, Jan 2011. DOI: https://doi.org/10.14776/kjpid.2011.18.1.61
  9. N. Nantachit, P. Kochjan, P. Khamrin, K. Kumthip, and N. Maneekarn, "Human bocavirus genotypes 1, 2, and 3 circulating in pediatric patients with acute gastroenteritis in Chiang Mai, Thailand, 2012-2018," Journal of Infection and Public Health, Vol. 14, No. 2, pp. 179-186, Feb 2021. DOI:https://doi.org/10.1016/j.jiph.2020.2.007
  10. R. Abdelqader, H. Hasan, and L. Alanagreh, "Epidemiology of Human Bocavirus in the Middle East and North Africa: Systematic Review," Pathogens, Vol. 10, No. 11, 1456, Nov 2021. DOI:https://doi.org/10.3390/pathog ens10111456
  11. T.M. Tessier, M.J. Dodge, K.M. MacNeil, A.M. Evans, M.A. Prusinkiewicz, and J.S. Mymryk, "Almost famous: Human adenoviruses (and what they have taught us about cancer)," Tumour Virus Research, Vol. 12, 200225, Dec 2021. DOI: https://doi.org/10.1016/j.tvr.2021.200225
  12. M.Y. Wu, L. Yao, Y. Wang, X.Y. Zhu, X.F. Wang, P.J. Tang, et al., "Clinical evaluation of potential usefulness of serum lactate dehydrogenase (LDH) in 2019 novel coronavirus (COVID-19) pneumonia," Respiratory Research, Vol. 21, No. 1, 171, July 2020.
  13. L. Cipolloni, F. Sessa, G. Bertozzi, B. Baldari, S. Cantatore, R. Testi R, et al., "Preliminary Post-Mortem COVID-19 Evidence of Endothelial Injury and Factor VIII Hyperexpression," Diagnostics (Basel), Vol. 10, No. 8, 575, Aug 2020. DOI: https://doi.org/10.3390/diagnostics10080575
  14. L. Ma, W. Wang, J.M. Le Grange, X. Wang, S. Du, C. Li, et al., "Coinfection of SARS-CoV-2 and other respiratory pathogens," Infection and Drug Resistance, Vol. 13, pp. 3045-3053, Aug 2020. DOI: 10.2147/IDR.S267238
  15. K. Sreenath, P. Batra, E.V. Vinayaraj, R. Bhatia, K. SaiKiran, V. Singh, et al., "Coinfections with other respiratory pathogens among patients with COVID-19," Microbiology Spectrum, Vol. 9, No. 1, e0016321, Sept 2021. DOI:https://doi.org/10.1128/Spectrum.00163-21
  16. J.C. Motta and C.C. Gomez, "Adenovirus and novel coronavirus (SARS-CoV-2) coinfection: A case report," IDCases, Vol. 22, e00936, Aug 2020. DOI:https://doi.org/10.1016/j.idcr.2020.e00936
  17. Z. Guan, C. Chen, Y. Li, C. Yan, X. Zhang, D. Jiang, et al., "Impact of Coinfection with SARS-CoV-2 and Influenza on Disease Severity: A Systematic Review and Meta-Analysis," Frontiers in Public Health. Vol. 9, 773130, Dec 2021. DOI:https://doi.org/10.3389/fpubh.2021.773130
  18. X. Xiang, Z.H. Wang, L.L. Ye, X.L. He, X.S. Wei, Y.L. Ma, et al, "Co-infection of SARS-COV-2 and influenza A virus: A case series and fast review," Current Medical Science, Vol. 41, No. 1, pp. 51-57, Feb 2021. DOI: https://doi.org/10.1007/s11596-021-2317-2